Endurant Capital Management’s ResMed RMD Stock Holding History

Endurant Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,345	Closed	-$1.39M	–	55
2023 Q1	$1.39M	Buy	+6,345	New	+$1.38M	0.71%	37

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Endurant Capital Management's RMD Position: Q2 2023 in Review

Endurant Capital Management sold out of ResMed (RMD) in Q2 2023, closing a stake of 6,345 shares — an estimated $1.39M sold.

Endurant Capital Management first reported a position in RMD in Q1 2023 and held it in 1 quarter. The position peaked at $1.39M in Q1 2023. 731 funds tracked by Wall St. Rank hold RMD as of Q2 2023.

Endurant Capital Management reported no remaining ResMed position as of Q2 2023 after selling out during the quarter.
Endurant Capital Management sold 6,345 ResMed shares in Q2 2023, an estimated $1.39M.
Endurant Capital Management first reported a position in ResMed in Q1 2023 and held it in 1 quarter.
Endurant Capital Management's ResMed position peaked at $1.39M in Q1 2023.
731 funds tracked by Wall St. Rank held ResMed as of Q2 2023.

Based on Endurant Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.